Answers are grounded in this paper and cite their sources.
A series of beta-D-2',3'-didehydro-2',3'-dideoxy-nucleosides bearing a tether attached at the C-5 position and their beta-L-counterparts was synthesized. Their inhibitory activities against human immunodeficiency virus (HIV) were investigated and compared to establish relationship(s) between compound structure and their antiviral activity. No significant activity was observed for beta-D- and beta-L-modified nucleosides respectively 7a-c and 14a-c, but 7d and 14d exhibited a weak activity against HIV-1.
No takes yet. Share an insight, caveat, or question.
Delbederi et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: